Literature DB >> 12821457

Persistent bacteremia in rabbit fetuses despite maternal antibiotic therapy in a novel intrauterine-infection model.

C Gras-Le Guen1, T Debillon, C Toquet, A Jarry, N Winer, C Jacqueline, M F Kergueris, E Bingen, J C Roze, G Potel, D Bugnon.   

Abstract

The effect of optimized maternal therapy by bactericidal agents was evaluated in a reproducible rabbit model of Escherichia coli maternofetal infection simulating human pharmacokinetics. Intravenous antibiotic therapy was begun in the pregnant rabbit 12 h after bacterial intrauterine inoculation, using a computer-controlled pump to simulate human pharmacokinetics of ceftriaxone (1 g/day) associated or not with gentamicin (3 mg/kg of body weight/day). Data were compared for fetal survival, quantitative blood cultures, fetal histology in treated versus untreated groups, and maternal and fetal antibiotic concentrations in plasma in treated animals. Antibiotic therapy led to dramatic improvement in maternal outcome (100% survival versus 100% death in the untreated group in association with maternal septicemia). Fetal survival also improved, with the two-drug combination providing a more potent effect. After 3 days of treatment, 32% of fetuses survived with one-drug therapy and 62% with two-drug therapy (Yates corrected chi(2), P < 0.05). In untreated animals, bacterial counts in blood cultures increased rapidly during the first 24 h up to 8.1 +/- 0.5 log CFU/ml, but remained relatively constant at all times with antibiotic treatment: 4.5 +/- 0.7 log CFU/ml at the start of treatment and 6.2 +/- 0.4 and 5.2 +/- 0.9 log CFU/ml after 72 h for one- and two-drug therapy, respectively (data are means +/- standard deviations). The failure of animals to be cured after 3 days of treatment was not due to an inadequate concentration of ceftriaxone, as the residual level in fetal serum at sacrifice was more than 1000 times the MIC of the microbe. Unexpectedly, inflammation in fetal lung decreased in the treated group after as little as 24 h of antibiotic therapy, despite persistent bacteremia. Although maternal outcome improved and drug concentrations were above the MIC, the treatment did not achieve sterilization of fetuses in utero for this rabbit E. coli maternofetal infection. However, fetal survival showed some improvement, and the histologic features of lung inflammation were reduced.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12821457      PMCID: PMC161868          DOI: 10.1128/AAC.47.7.2125-2130.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  Intrauterine infection induces programmed cell death in rabbit periventricular white matter.

Authors:  T Debillon; C Gras-Leguen; V Vérielle; N Winer; J Caillon; J C Rozé; P Gressens
Journal:  Pediatr Res       Date:  2000-06       Impact factor: 3.756

2.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors:  S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

3.  Haemophilus influenzae meningitis in infant rats after intranasal inoculation.

Authors:  E R Moxon; A L Smith; D R Averill; D H Smith
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

4.  Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma.

Authors:  M E Jolley; S D Stroupe; C H Wang; H N Panas; C L Keegan; R L Schmidt; K S Schwenzer
Journal:  Clin Chem       Date:  1981-07       Impact factor: 8.327

5.  Chronic intrauterine infection and inflammation in the preterm rabbit, despite antibiotic therapy.

Authors:  Ronald S Gibbs; Jill K Davies; Robert S McDuffie; Kimberly K Leslie; Michael P Sherman; Charles A Centretto; Douglas M Wolf
Journal:  Am J Obstet Gynecol       Date:  2002-02       Impact factor: 8.661

6.  Histologic inflammation in the maternal and fetal compartments in a rabbit model of acute intra-amniotic infection.

Authors:  J K Davies; R H Shikes; C I Sze; K K Leslie; R S McDuffie; R Romero; R S Gibbs
Journal:  Am J Obstet Gynecol       Date:  2000-11       Impact factor: 8.661

Review 7.  Infection and preterm birth.

Authors:  W W Andrews; J C Hauth; R L Goldenberg
Journal:  Am J Perinatol       Date:  2000       Impact factor: 1.862

Review 8.  Relevance of animal models for clinical treatment.

Authors:  W Craig
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

9.  Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics.

Authors:  P D Damper; W Epstein
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

10.  A rabbit model for ascending infection in pregnancy: intervention with indomethacin and delayed ampicillin-sulbactam therapy.

Authors:  L Heddleston; R S McDuffie; R S Gibbs
Journal:  Am J Obstet Gynecol       Date:  1993-09       Impact factor: 8.661

View more
  3 in total

1.  Efficacy of ciprofloxacin in an experimental model of Escherichia coli chorioamnionitis in rabbits.

Authors:  Elise Launay; Nicolas Joram; Cédric Jacqueline; Anne Francoise Miegeville; Jocelyne Caillon; Gilles Potel; Jean Christophe Roze; Christèle Gras-Le Guen
Journal:  Antimicrob Agents Chemother       Date:  2009-01-21       Impact factor: 5.191

2.  Intra-amniotic administration of exogenous pulmonary surfactant for improving in lung maturity of fetal rabbits with intrauterine infection caused by premature rupture of membranes.

Authors:  Jing Liu; Jing Wu; Na Yang; ZhiChun Feng
Journal:  Bosn J Basic Med Sci       Date:  2011-05       Impact factor: 3.363

3.  Interleukin-19 in fetal systemic inflammation.

Authors:  Zeynep Alpay Savasan; Tinnakorn Chaiworapongsa; Roberto Romero; Youssef Hussein; Juan Pedro Kusanovic; Yi Xu; Zhong Dong; Chong Jai Kim; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2012-04-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.